The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib

被引：0
|
作者：
Gong Xueqian
Chio, Li-Chun
Webster, Yue
Lallena, Maria Jose
Boehnke, Karsten
Torres, Raquel
Iversen, Phil
De Dios, Alfonso
Smith, Ian
Reinhard, Christoph
Peng, Sheng-Bin
Dempsey, Jack
Burke, Teresa
Chen, Shih-Hsun
Stewart, Trent
Beckmann, Richard
Wu, Wenjuan
Buchanan, Sean G.
机构：
来源：
MOLECULAR CANCER RESEARCH | 2016年 / 14卷
关键词：
D O I：
10.1158/1557-3125.CELLCYCLE16-A07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A07
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas
    Liang, Muh-Lii
    Chen, Chun-Han
    Liu, Yun-Ru
    Huang, Man-Hsu
    Lin, Yu-Chen
    Wong, Tai-Tong
    Lin, Sey-En
    Chu, Shing-Shiung
    Ding, Yi-Huei
    Hsieh, Tsung-Han
    [J]. CANCERS, 2020, 12 (12) : 1 - 17
  • [22] Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
    Raub, Thomas J.
    Wishart, Graham N.
    Kulanthaivel, Palaniappan
    Staton, Brian A.
    Ajamie, Rose T.
    Sawada, Geri A.
    Gelbert, Lawrence M.
    Shannon, Harlan E.
    Sanchez-Martinez, Concepcion
    De Dios, Alfonso
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (09) : 1360 - 1371
  • [23] Different mechanism of CDK4/6 inhibitor resistance between ribociclib and abemaciclib
    Iida, Masafumi
    Toyosawa, Daichi
    Nakamura, Misato
    Tokuda, Emi
    Niwa, Toshifumi
    Yoshida, Ryuichi
    Ishida, Takanori
    Hayashi, Shin-ichi
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [24] A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
    Chong, Qing-Yun
    Kok, Ze-Hui
    Bui, Ngoc-Linh-Chi
    Xiang, Xiaoqiang
    Wong, Andrea Li-Ann
    Yong, Wei-Peng
    Sethi, Gautam
    Lobie, Peter E.
    Wang, Lingzhi
    Goh, Boon-Cher
    [J]. PHARMACOLOGICAL RESEARCH, 2020, 156
  • [25] MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma
    Bustos, Matias A.
    Ono, Shigeshi
    Marzese, Diego M.
    Oyama, Takashi
    Iida, Yuuki
    Cheung, Garrett
    Nelson, Nellie
    Hsu, Sandy C.
    Yu, Qiang
    Hoon, Dave S. B.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (09) : 1955 - 1964
  • [26] CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer
    Li, Qing
    Razavi, Pedram
    Li, Zhiqiang
    Paula, Arnaud F. Da Cruz
    Brogi, Edi
    Scaltriti, Maurizio
    Reis-Filho, Jorge S.
    Chandarlapaty, Sarat
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [27] Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
    Patnaik, Amita
    Rosen, Lee S.
    Tolaney, Sara M.
    Tolcher, Anthony W.
    Goldman, Jonathan W.
    Gandhi, Leena
    Papadopoulos, Kyriakos P.
    Beeram, Muralidhar
    Rasco, Drew W.
    Hilton, John F.
    Nasir, Aejaz
    Beckmann, Richard P.
    Schade, Andrew E.
    Fulford, Angie D.
    Nguyen, Tuan S.
    Martinez, Ricardo
    Kulanthaivel, Palaniappan
    Li, Lily Q.
    Frenzel, Martin
    Cronier, Damien M.
    Chan, Edward M.
    Flaherty, Keith T.
    Wen, Patrick Y.
    Shapiro, Geoffrey I.
    [J]. CANCER DISCOVERY, 2016, 6 (07) : 740 - 753
  • [28] The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes
    Paternot, Sabine
    Colleoni, Bianca
    Bisteau, Xavier
    Roger, Pierre P.
    [J]. CELL CYCLE, 2014, 13 (18) : 2879 - 2888
  • [29] CDK4 and CDK6 kinases: From basic science to cancer therapy
    Fassl, Anne
    Geng, Yan
    Sicinski, Piotr
    [J]. SCIENCE, 2022, 375 (6577) : 158 - +
  • [30] IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER
    Petroni, Giulia
    Gouin, Kenneth
    Martinez, Aitziber Buque
    Knott, Simon
    Formenti, Silvia
    Galluzzi, Lorenzo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A763 - A763
12345